Company
graphtx.com
Decoding Immune Dysfunction at Scale
Also known as Graph Therapeutics FlexCo, GraphTx
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Vienna, Austria
- Legal name
- Graph Therapeutics FlexCo
- graphtx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
GraphTx is pioneering a new approach to precision immunology. We front-load clinical development by identifying and validating drug targets in live patient samples, long before the clinical trial begins. Our AI-driven platform systematically captures, perturbs, and decodes patient immune biology at unprecedented scale, transforming chaotic cellular data into actionable therapeutic insights.
Funding snapshot
- Total raised
- $3.1MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Undisclosed2026-06-22
Funding rounds
- Round, 2026
- 2026-06-22
- Grant
- 2025-03-03
- Pre seed
- $3.1M2024-12-10, Company stated
Loading relationship preview